IDT Biologika - A CDMO With End-to-End Services In Vaccines, Cell & Gene Therapeutics, And Fill-Finish Of Biologics

Our mission is to accelerate the development and manufacturing of our client‘s therapeutic and prophylactic products to treat serious diseases, that impact human health worldwide.

IDT Biologika is a globally operating CDMO that specializes in vaccines and advanced therapies, as well as the commercial fill-finish of biologics and sterile injectables:

At our sites in Maryland and Germany, we provide fully integrated services for clinical and commercial GMP manufacturing, which include process development, drug substance manufacturing, aseptic fill-finish, packaging, and quality control & analytics. Our state-ot-the-art facilities are FDA, EMA, and ANVISA approved.

With more than 100 years of expertise in vaccines and more than 30 years in commercial fill-finish, we have established the most innovative platform technologies and aseptic processes.

Leading multinational pharmaceutical and biotechnology companies trust us for our expertise and reliability in the commercial manufacturing of vaccines and biologics.

To keep up with the needs of our clients, we have significantly expanded our drug substance and aseptic fill-finish capacities. We are proud to be the first company with the approved status of pandemic preparedness, in Germany. United by our vision to bring any therapy to life, we also support our clients in the field of advanced therapies and have produced one of the first commercial CGT products approved by the FDA and EMA.

At IDT Biologika, we actively seek partnerships with biotech and pharmaceutical companies, leading academic institutions, and industry pioneers to accelerate the development and manufacturing of life-changing therapies to bring hope and improved quality of life to millions of individuals worldwide. We have experience working with customers of all sizes from top global multinational pharma to small companies.